Oragenics Inc (OGEN): Are Investors Missing The Big Picture?

Oragenics Inc (AMEX:OGEN) does about 332.22K shares in volume on a normal day but saw 8061893 shares change hands in the recent trading day. The company now has a market cap of 11.61M USD. Its current market price is $2.08, marking an increase of 48.57% compared to the previous close of $1.40. The 52 week high reached by this stock is $7.74 whilst the lowest price level in 52 weeks is $0.86.

Oragenics Inc (OGEN) has a 20-day trading average at $1.1000 and the current price is -73.13% off the 52-week high compared with 141.55% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.2800 and its 200-day simple moving average is $2.6000. If we look at the stock’s price movements over the week, volatility stands at 34.86%, which decreases to 12.64% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 81.31 to suggest the stock is overbought.

The consensus objective for the share price is $90.00, suggesting that the stock has a potential upside of 97.69% over the period.

Oragenics Inc (OGEN) stock is up 132.04% over the week and 86.55% over the past month. Its price is -63.03% year-to-date and -36.59% over the past year.

To reach the target analysts have set, the stock logically needs to grow 97.69 percent from here.

The company has a return on investment of -1471.37% and return on equity of -454.72%. The beta has a value of 0.38. Price to sales ratio is 1160.64.